Table 2.

CRS, ICANS, and adverse events after NS7CAR T-cell infusion*

CRS/ICANSGrade 1 (n)Grade 2 (n)Grade 3 (n)Grade 4 (n)
CRS 14 
 Fever (≥38°C) 19 
 Hypotension 
 Hypoxia 
ICANS 
 Decreased level of consciousness 
 Seizure 
 Impairment of motor functions 
 Elevated ICP or cerebral edema 
CRS/ICANSGrade 1 (n)Grade 2 (n)Grade 3 (n)Grade 4 (n)
CRS 14 
 Fever (≥38°C) 19 
 Hypotension 
 Hypoxia 
ICANS 
 Decreased level of consciousness 
 Seizure 
 Impairment of motor functions 
 Elevated ICP or cerebral edema 
Adverse eventsGrade 1 (n)Grade 2 (n)Grade 3 (n)Grade 4 (n)
Hematologic event     
 Anemia 17 
 Neutropenia 20 
 Lymphopenia 20 
 Thrombocytopenia 15 
Gastrointestinal event     
 Loss of appetite 
 Nausea/vomiting/diarrhea 
 Abdominal bloating 
Cardiovascular event     
 Chest pain 
 Tachycardia 10 
 Heart failure 
General conditions     
 Fatigue 
 Flu-like symptom 
 Rash 
 Peripheral edema 
Laboratory values     
 AST increase 
 ALT increase 
 Bilirubin increase 
 Creatine increase 
 LDH increase 19 
Infection     
 Sepsis 
 Lung infection 
 Skin infection 
 Oral ulcer 
 CMV activation 
 Coagulopathy 
Adverse eventsGrade 1 (n)Grade 2 (n)Grade 3 (n)Grade 4 (n)
Hematologic event     
 Anemia 17 
 Neutropenia 20 
 Lymphopenia 20 
 Thrombocytopenia 15 
Gastrointestinal event     
 Loss of appetite 
 Nausea/vomiting/diarrhea 
 Abdominal bloating 
Cardiovascular event     
 Chest pain 
 Tachycardia 10 
 Heart failure 
General conditions     
 Fatigue 
 Flu-like symptom 
 Rash 
 Peripheral edema 
Laboratory values     
 AST increase 
 ALT increase 
 Bilirubin increase 
 Creatine increase 
 LDH increase 19 
Infection     
 Sepsis 
 Lung infection 
 Skin infection 
 Oral ulcer 
 CMV activation 
 Coagulopathy 

ALT, alanine aminotransferase; AST, aspartate aminotransferase; ICP, increased intracranial pressure; LDH, lactate dehydrogenase.

*

CRS/ICANS and adverse events reported from NS7CAR T-cell infusion to day 30 after infusion.

Four patients had mild hypotension, but vasopressors were not required.

Close Modal

or Create an Account

Close Modal
Close Modal